Predictors of sex-specific resistance to caTAUstrophe
Carrigan, M.; Birkenbihl, C.; Klinger, H. M.; Langford, O.; Coughlan, G. T.; Seto, M.; Brown, J. A.; Li, A.; Cuppels, M.; Properzi, M.; Chhatwal, J.; Price, J.; Schultz, A.; Rentz, D.; Amariglio, R.; Krugers, H. J.; Ossenkoppele, R.; Johnson, K.; Sperling, R.; Hohman, T. J.; Donohue, M. C.; Buckley, R. F.
Show abstract
INTRODUCTIONAs {beta}-amyloid(A{beta}) accumulates, tau pathology spreads beyond medial temporal(MTL) regions into the neocortex, though some older adults resist this progression, or caTAUstrophe. Given previous evidence of higher tau levels in women, we tested whether tau resistance presents differently in A{beta}+ men and women. METHODSEmploying data from 872 A{beta}+ older adults(NTest=579) across three cohorts, we estimated resistance, defined as the deviation from participants expected level of neocortical tau. Models predicting the expected tau levels were trained separately in females(NTrain=172) and males(NTrain=121) experiencing typical tau progression to assess sex-specific resistance. RESULTSRelative feature importance in female-only and male-only expectation models differed in 97.7% of variables(p[FDR]<0.001). Moreover, age and A{beta} burden predicted male resistance, while CDR, latent PACC, and adjusted hippocampal volume were predictors for both sexes. DISCUSSIONOur study highlights the impact of sex-specific characteristics in the prediction of neocortical tau resistance. Understanding sex-specific resistance pathways informs targeted Alzheimers interventions.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Metacognition, cortical thickness, and tauopathy in aging 96%
- The spatial distribution of coupling between tau and neurodegeneration in amyloid-β positive mild cognitive impairment 96%
- Integrating plasma, MRI, and cognitive biomarkers for personalized prediction of decline across cognitive domains 95%
Similar papers in this journal
- Medial temporal lobe atrophy patterns in early- versus late-onset amnestic Alzheimer's disease 97%
- Tau-PET and in vivo Braak-staging as a prognostic marker in Alzheimer’s disease 96%
- Head-to-head comparison between plasma p-tau217 and Flortaucipir-PET in amyloid-positive patients with cognitive impairment 96%
Similar papers in this journal
- FMRI complexity correlates with tau-PET in Late-Onset and Autosomal Dominant Alzheimer's Disease 96%
- Effect of Pathway-specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals 96%
- Disentangling the distal association between β-Amyloid and tau pathology at varying stages of tau deposition 95%